Cardiology

Correction of cardiovascular symptoms of MPS I in animal model

REGENXBIO Inc. today announced that gene transfer mediated by REGENXBIO's NAV AAV8 vectors resulted in sustained serum α-L-iduronidase (IDUA) expression, as well as correction of systemic features of MPS I, or Hurler syndrome, ...

Diseases, Conditions, Syndromes

Fight back against MRSA to be started with a sniff

An innovative anti-bacterial spray that will kill MRSA is being developed by Norwich Research Park scientists thanks to funding from the University of East Anglia.

page 5 from 5